25 years of neuroimaging in amyotrophic lateral sclerosis

Nature Reviews Neurology

Volumn 9, Issue 9, 2013, Pages 513-524

  Foerster, Bradley R ^a   Welsh, Robert C ^a   Feldman, Eva L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 6 FLUORODOPA F 18; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; INOSITOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; RADIOISOTOPE; SELEGILINE C 11; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN STEM; CERVICAL SPINAL CORD; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FRONTAL LOBE; GRAY MATTER; HUMAN; MOTOR CORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL TRACT; RESTING STATE FUNCTIONAL CONNECTIVITY NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; STRUCTURAL NUCLEAR MAGNETIC RESONANCE IMAGING; VOXEL BASED MORPHOMETRY; WHITE MATTER;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

EID: 84883740172     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.153     Document Type: Review

References (136)

1. Kumar, D. R., Aslinia, F., Yale, S. H. & Mazza, J. J. Jean-Martin Charcot: the father of neurology. Clin. Med. Res. 9, 46-49 (2011).
2. Turner, M. R. MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers? Biomark. Med. 5, 79-81 (2011).
3. Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942-955 (2011).
4. Zoccolella, S. et al. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J. Neurol. Sci. 250, 45-49 (2006). (Pubitemid 44679704)
5. Comi, G., Rovaris, M. & Leocani, L. Neuroimaging in amyotrophic lateral sclerosis. Eur. J. Neurol. 6, 629-637 (1999).
6. Ngai, S., Tang, Y. M., Du, L. & Stuckey, S. Hyperintensity of the precentral gyral subcortical white matter and hypointensity of the precentral gyrus on fluid-attenuated inversion recovery: variation with age and implications for the diagnosis of amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 28, 250-254 (2007). (Pubitemid 46281039)
7. Deichmann, R., Good, C. D., Josephs, O., Ashburner, J. & Turner, R. Optimization of 3-D MP-RAGE sequences for structural brain imaging. Neuroimage 12, 112-127 (2000). (Pubitemid 30602069)
8. Traynor, C. R., Barker, G. J., Crum, W. R., Williams, S. C. & Richardson, M. P. Segmentation of the thalamus in MRI based on T1 and T2. Neuroimage 56, 939-950 (2011).
9. Ashburner, J. & Friston, K. J. Voxel-based morphometry-the methods. Neuroimage 11, 805-821 (2000). (Pubitemid 30437668)
10. Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl Acad. Sci. USA 97, 11050-11055 (2000).
11. Das, S. R., Avants, B. B., Grossman, M. & Gee, J. C. Registration based cortical thickness measurement. Neuroimage 45, 867-879 (2009).
12. Chenevert, T. L., Brunberg, J. A. & Pipe, J. G. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177, 401-405 (1990). (Pubitemid 20374856)
13. Pierpaoli, C. & Basser, P. J. Toward a quantitative assessment of diffusion anisotropy. Magn. Reson. Med. 36, 893-906 (1996). (Pubitemid 26396817)
14. Dong, Q. et al. Clinical applications of diffusion tensor imaging. J. Magn. Reson. Imaging 19, 6-18 (2004). (Pubitemid 38055724)
15. Castillo, M., Kwock, L. & Mukherji, S. K. Clinical applications of proton MR spectroscopy. AJNR Am. J. Neuroradiol. 17, 1-15 (1996). (Pubitemid 26024702)
16. Kalra, S. & Arnold, D. L. ALS surrogate markers. MRS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5 (Suppl. 1), 111-114 (2004).
17. Damoiseaux, J. S. et al. Consistent resting-state networks across healthy subjects. Proc. Natl Acad. Sci. USA 103, 13848-13853 (2006). (Pubitemid 44413996)
18. Biswal, B. B., Van Kylen, J. & Hyde, J. S. Simultaneous assessment of flow and BOLD signals in resting-state functional connectivity maps. NMR Biomed. 10, 165-170 (1997). (Pubitemid 27519913)
19. Turner, M. R. et al. Neuroimaging in amyotrophic lateral sclerosis. Biomark. Med. 6, 319-337 (2012).
20. Pike, V. W. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol. Sci. 30, 431-440 (2009).
21. Kiernan, J. A. & Hudson, A. J. Frontal lobe atrophy in motor neuron diseases. Brain 117, 747-757 (1994). (Pubitemid 24281837)
22. Ellis, C. M. et al. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology 57, 1571-1578 (2001). (Pubitemid 33055472)
23. Mezzapesa, D. M. et al. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 28, 255-259 (2007). (Pubitemid 46281040)
24. Chang, J. L. et al. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 65, 75-80 (2005). (Pubitemid 40967780)
25. Kassubek, J. et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6, 213-220 (2005).
26. Grosskreutz, J. et al. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol. 6, 17 (2006).
27. Turner, M. R. et al. Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 8, 343-347 (2007). (Pubitemid 350176932)
28. Agosta, F. et al. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum. Brain Mapp. 28, 1430-1438 (2007). (Pubitemid 350237659)
29. Roccatagliata, L., Bonzano, L., Mancardi, G., Canepa, C. & Caponnetto, C. Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10, 47-52 (2009).
30. Verstraete, E. et al. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 83, 383-388 (2012).
31. Agosta, F. et al. The cortical signature of amyotrophic lateral sclerosis. PLoS ONE 7, e42816 (2012).
32. Libon, D. J. et al. Deficits in concept formation in amyotrophic lateral sclerosis. Neuropsychology 26, 422-429 (2012).
33. Agosta, F. et al. Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: a tensor based morphometry study. Amyotroph. Lateral Scler. 10, 168-174 (2009).
34. Sudharshan, N. et al. Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy. AJNR Am. J. Neuroradiol. 32, 403-407 (2011).
35. Pyra, T. et al. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 11, 157-165 (2010).
36. Sarchielli, P. et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 43, 189-197 (2001). (Pubitemid 32194473)
37. Wang, S. et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 239, 831-838 (2006). (Pubitemid 43830620)
38. Mitsumoto, H. et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 68, 1402-1410 (2007). (Pubitemid 46659092)
39. Pohl, C. et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch. Neurol. 58, 729-735 (2001). (Pubitemid 32423044)
40. Bowen, B. C. et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 21, 647-658 (2000). (Pubitemid 30210426)
41. Rule, R. R. et al. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5, 141-149 (2004). (Pubitemid 39406513)
42. Abe, K. et al. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 43, 537-541 (2001). (Pubitemid 32677184)
43. Lombardo, F. et al. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis. Arch. Ital. Biol. 147, 69-82 (2009).
44. Schuff, N. et al. Reanalysis of multislice 1H MRSI in amyotrophic lateral sclerosis. Magn. Reson. Med. 45, 513-516 (2001). (Pubitemid 32173280)
45. Bradley, W. G., Bowen, B. C., Pattany, P. M. & Rotta, F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J. Neurol. Sci. 169, 84-86 (1999). (Pubitemid 29502512)
46. Han, J. & Ma, L. Study of the features of proton MR spectroscopy (1H-MRS) on amyotrophic lateral sclerosis. J. Magn. Reson. Imaging 31, 305-308 (2010).
47. Sivak, S. et al. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 52, 1079-1085 (2010).
48. van der Graaff, M. M. et al. MR spectroscopy findings in early stages of motor neuron disease. AJNR Am. J. Neuroradiol. 31, 1799-1806 (2010).
49. Ellis, C. M. et al. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 51, 1104-1109 (1998). (Pubitemid 28473408)
50. Unrath, A., Ludolph, A. C. & Kassubek, J. Brain metabolites in definite amyotrophic lateral sclerosis. a longitudinal proton magnetic resonance spectroscopy study. J. Neurol. 254, 1099-1106 (2007). (Pubitemid 47353424)
51. Kalra, S., Hanstock, C. C., Martin, W. R., Allen, P. S. & Johnston, W. S. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch. Neurol. 63, 1144-1148 (2006). (Pubitemid 44232322)
52. Kaufmann, P. et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 62, 1753-1757 (2004). (Pubitemid 38661730)
53. Foerster, B. R. et al. Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis. Neurology 78, 1596-1600 (2012).
54. Mohammadi, B. et al. Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp. Neurol. 217, 147-153 (2009).
55. Jelsone-Swain, L. M. et al. Reduced interhemispheric functional connectivity in the motor cortex during rest in limb-onset amyotrophic lateral sclerosis. Front. Syst. Neurosci. 4, 158 (2010).
56. Tedeschi, G. et al. Interaction between aging and neurodegeneration in amyotrophic lateral sclerosis. Neurobiol. Aging 33, 886-898 (2012).
57. Verstraete, E. et al. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS ONE 2012, e13664 (2010).
58. Agosta, F. et al. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb. Cortex 21, 2291-2298 (2011).
59. Douaud, G., Filippini, N., Knight, S., Talbot, K. & Turner, M. R. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain 134, 3470-3479 (2011).
60. Zanette, G. et al. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J. Neurol. 249, 1723-1728 (2002). (Pubitemid 36269267)
61. Kew, J. J. et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 116, 655-680 (1993). (Pubitemid 23203643)
62. Turner, M. R. et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 15, 601-609 (2004). (Pubitemid 38429975)
63. Turner, M. R. et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain 128, 1323-1329 (2005). (Pubitemid 40826186)
64. Turner, M. R. et al. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J. Neurol. Neurosurg. Psychiatry 76, 1279-1285 (2005). (Pubitemid 41208385)
65. Turner, M. R. & Kiernan, M. C. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. 13, 245-250 (2012).
66. Thivard, L. et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J. Neurol. Neurosurg. Psychiatry 78, 889-892 (2007). (Pubitemid 47204601)
67. Abe, O. et al. Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed. 17, 411-416 (2004). (Pubitemid 39335180)
68. Agosta, F. et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am. J. Neuroradiol. 31, 1457-1461 (2010).
69. Cosottini, M. et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 237, 258-264 (2005). (Pubitemid 41346172)
70. Cosottini, M. et al. Evaluation of corticospinal tract impairment in the brain of patients with amyotrophic lateral sclerosis by using diffusion tensor imaging acquisition schemes with different numbers of diffusion-weighting directions. J. Comput. Assist. Tomogr. 34, 746-750 (2010).
71. Filippini, N. et al. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 75, 1645-1652 (2010).
72. Iwata, N. K. et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134, 2642-2655 (2011).
73. Iwata, N. K. et al. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 70, 528-532 (2008). (Pubitemid 351653377)
74. Sage, C. A., Peeters, R. R., Gorner, A., Robberecht, W. & Sunaert, S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 34, 486-499 (2007). (Pubitemid 44830171)
75. Sach, M. et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 127, 340-350 (2004). (Pubitemid 38160319)
76. Chapman, M. C., Jelsone-Swain, L. M., Johnson, T. D., Gruis, K. L. & Welsh, R. C. Diffusion tensor MRI of the corpus callosum in amyotrophic lateral sclerosis. J. Magn. Res. Imaging http://dx.doi.org/10.1002/jmri.24218.
77. Ben Bashat, D. et al. A potential tool for the diagnosis of ALS based on diffusion tensor imaging. Amyotroph. Lateral Scler. 12, 398-405 (2011).
78. Stagg, C. J. et al. Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology 80, 610-615 (2013).
79. Metwalli, N. S. et al. Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis. Brain Res. 1348, 156-164 (2010).
80. van der Graaff, M. M. et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain 134, 1211-1228 (2011).
81. Ellis, C. M. et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53, 1051-1058 (1999). (Pubitemid 29442122)
82. Prell, T. et al. Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg. http://dx.doi.org/10.1016/j.clineuro.2012.11.031.
83. Blain, C. R. et al. Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. J. Neurol. Neurosurg. Psychiatry 82, 843-849 (2011).
84. Schimrigk, S. K. et al. Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model. Am. J. Neuroradiol. 28, 724-730 (2007). (Pubitemid 46608615)
85. Graham, J. M. et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 63, 2111-2119 (2004). (Pubitemid 39636260)
86. Senda, J. et al. Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: a study with tractography and diffusion-tensor imaging. Amyotroph. Lateral Scler. 10, 288-294 (2009).
87. Ciccarelli, O. et al. Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum. Brain Mapp. 30, 615-624 (2009).
88. Toosy, A. T. et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 74, 1250-1257 (2003).
89. Menke, R. A. et al. Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch. Neurol. 69, 1493-1499 (2012).
90. Keil, C. et al. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci. 13, 141 (2012).
91. Zhang, Y. et al. Progression of white matter degeneration in amyotrophic lateral sclerosis: a diffusion tensor imaging study. Amyotroph. Lateral Scler. 12, 421-429 (2011).
92. Agosta, F. et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry 80, 53-55 (2009).
93. Blain, C. R. et al. A longitudinal study of diffusion tensor MRI in ALS. Amyotroph. Lateral Scler. 8, 348-355 (2007). (Pubitemid 350176933)
94. Verstraete, E., Veldink, J. H., Mandl, R. C., van den Berg, L. H. & van den Heuvel, M. P. Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS ONE 6, e24239 (2011).
95. Ravits, J. M. & La Spada, A. R. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73, 805-811 (2009).
96. Yin, H. et al. Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J. Neurol. 251, 1249-1254 (2004). (Pubitemid 39517929)
97. Govind, V. et al. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PLoS ONE 7, e35607 (2012).
98. Song, S. K. et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26, 132-140 (2005).
99. Smith, M. C. Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 23, 269-282 (1960).
100. Song, S. K. et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20, 1714-1722 (2003).
101. Cirillo, M. et al. Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am. J. Neuroradiol. 33, 1102-1108 (2012).
102. Yamauchi, H. et al. Corpus callosum atrophy in amyotrophic lateral sclerosis. J. Neurol. Sci. 134, 189-196 (1995).
103. Chapman, M. C. et al. Corpus callosum area in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 13, 589-591 (2012).
104. Ashburner, J. & Friston, K. J. Why voxel-based morphometry should be used. Neuroimage 14, 1238-1243 (2001). (Pubitemid 33124172)
105. Bartels, C. et al. Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscul. Disord. 18, 398-407 (2008).
106. Bak, T. H. & Chandran, S. What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex 48, 936-944 (2012).
107. Abrahams, S. et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J. Neurol. 252, 321-331 (2005). (Pubitemid 40562165)
108. Murphy, J. M. et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch. Neurol. 64, 530-534 (2007). (Pubitemid 46588341)
109. Senda, J. et al. Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph. Lateral Scler. 12, 59-69 (2011).
110. Usman, U. et al. Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study. AJNR Am. J. Neuroradiol. 32, 1677-1680 (2011).
111. Sarro, L. et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. AJNR Am. J. Neuroradiol. 32, 1866-1872 (2011).
112. Tsujimoto, M. et al. Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. J. Neurol. Sci. 307, 34-40 (2011).
113. Schreiber, H. et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J. Neurol. 252, 772-781 (2005). (Pubitemid 40984851)
114. Abrahams, S. et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 119, 2105-2120 (1996).
115. Tanaka, M. et al. Cerebral blood flow and oxygen metabolism in progressive dementia associated with amyotrophic lateral sclerosis. J. Neurol. Sci. 120, 22-28 (1993). (Pubitemid 24011143)
116. Cistaro, A. et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur. J. Nucl. Med. Mol. Imaging 39, 251-259 (2012).
117. Wicks, P. et al. Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study. Amyotroph. Lateral Scler. 9, 43-49 (2008). (Pubitemid 351260372)
118. Turner, M. R. et al. Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS. Neurology 68, 1233-1235 (2007). (Pubitemid 46608476)
119. DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256 (2011).
120. Sharma, K. R., Sheriff, S., Maudsley, A. & Govind, V. Diffusion tensor imaging of basal ganglia and thalamus in amyotrophic lateral sclerosis. J. Neuroimaging 23, 368-374 (2012).
121. Sharma, K. R., Saigal, G., Maudsley, A. A. & Govind, V. 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis. NMR Biomed. 24, 1270-1276 (2011).
122. Takahashi, H. et al. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342, 1016-1018 (1993). (Pubitemid 23314803)
123. Pioro, E. P., Majors, A. W., Mitsumoto, H., Nelson, D. R. & Ng, T. C. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 53, 71-79 (1999). (Pubitemid 29329651)
124. Johansson, A. et al. Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET. J. Neurol. Sci. 255, 17-22 (2007). (Pubitemid 46415796)
125. Valsasina, P. et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 78, 480-484 (2007). (Pubitemid 46662895)
126. Cohen-Adad, J. et al. Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 30-38 (2013).
127. Ikeda, K. et al. Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis. Muscle Nerve 47, 61-67 (2013).
128. Carew, J. D. et al. Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology 77, 1370-1375 (2011).
129. Carew, J. D. et al. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 12, 185-191 (2011).
130. Foerster, B. R. et al. Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis. Acad. Radiol. 19, 1075-1086 (2012).
131. Turner, M. R. et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol. 10, 400-403 (2011).
132. Welsh, R. C., Jelsone-Swain, L. M. & Foerster, B. R. The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain. Front. Hum. Neurosci. 7, 1-7 (2013).
133. Testa, D., Lovati, R., Ferrarini, M., Salmoiraghi, F. & Filippini, G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5, 208-212 (2004). (Pubitemid 40125186)
134. Zoccolella, S. et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J. Neurol. Sci. 268, 28-32 (2008). (Pubitemid 351395319)
135. Kalra, S., Vitale, A., Cashman, N. R., Genge, A. & Arnold, D. L. Cerebral degeneration predicts survival in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 77, 1253-1255 (2006). (Pubitemid 44654756)
136. Agosta, F. et al. MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur. J. Neurosci. 32, 1490-1496 (2010).